Delivery Order SPE2DB20D3103-SPE2DB24FP4B4

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a delivery order with a ceiling value of $3,188.69 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a period of performance through December 17, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award, valued at $9,032.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as the...
This federal contract award, valued at $12,938.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565110719 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating...
This federal contract award is a delivery order valued at $2,413.62 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LIDOCAINE 5% PATCH 30S, a prescription medical product, and has a period of performance through June 12, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $9,856.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, and has an ultimate completion date of July 29, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This federal contract award is a delivery order worth $14,119.77 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LIDOCAINE 5% PATCH 30S, a topical anesthetic medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order valued at $8,413.29, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of June 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with a value of $2,861.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of May 21, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,209.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of November 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,701.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of February 11, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4B4
    Delivery Order

This federal contract award is a delivery order with a ceiling value of $12,774.19 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:54 AM